European Savings From Small-Molecule Generic Launches Likely To Tail Off
This article was originally published in The Pink Sheet Daily
Executive Summary
Encouraging use of generics is one of few policy measures over past decades to generate large savings for U.K.’s National Health Service, but time may be running out for European countries to make major savings from declining number of new small-molecule generics.